glp-1 obesity drug news today october 23 2025 Pharma Giants Bet on Next-Generation Treatments to Sustain Growth Use of diabetes and anti-obesity

Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes

[DOI] [PMC free article] [PubMed] [Google Scholar] 171.Lin H.V., Wang J., Wang J., Li W., Wang X., Alston J.T

HEK293T cells (obtained from and certified by the Cell Bank at the Chinese Academy of Sciences and confirmed as negative for mycoplasma contamination) were cultured in DMEM supplemented with 10% (v/v) foetal bovine serum, 50 IU mL 1 penicillin and 50 g mL 1 streptomycin

doi: 10.1016/j.cgh.2024.04.038

As the wealth of research continues to evolve, ongoing and future trials will help refine the role of GLP-1 RAs in a broader range of conditions and chart new therapies for the next generation of cardiovascular care